BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 30151681)

  • 1. Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.
    Gewandter JS; Chaudari J; Ibegbu C; Kitt R; Serventi J; Burke J; Culakova E; Kolb N; Sluka KA; Tejani MA; Mohile NA
    Support Care Cancer; 2019 May; 27(5):1765-1774. PubMed ID: 30151681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Proof-of-Concept Randomized Clinical Trial.
    Gewandter JS; Culakova E; Davis JN; Gada U; Guido JJ; Bearden JD; Burnette B; Shah D; Morrow GR; Mustian K; Sluka KA; Mohile N
    J Pain; 2024 May; 25(5):104431. PubMed ID: 37993030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial.
    Loprinzi C; Le-Rademacher JG; Majithia N; McMurray RP; O'Neill CR; Bendel MA; Beutler A; Lachance DH; Cheville A; Strick DM; Black DF; Tilburt JC; Smith TJ
    Support Care Cancer; 2020 Mar; 28(3):1183-1197. PubMed ID: 31209630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy.
    Wong R; Major P; Sagar S
    Integr Cancer Ther; 2016 Jun; 15(2):153-64. PubMed ID: 27130723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial-VANISH.
    Streckmann F; Hess V; Bloch W; Décard BF; Ritzmann R; Lehmann HC; Balke M; Koliamitra C; Oschwald V; Elter T; Zahner L; Donath L; Roth R; Faude O
    BMJ Open; 2019 Apr; 9(4):e024467. PubMed ID: 31023750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
    Knoerl R; Weller E; Halpenny B; Berry D
    BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors.
    Gewandter JS; Mohile SG; Heckler CE; Ryan JL; Kirshner JJ; Flynn PJ; Hopkins JO; Morrow GR
    Support Care Cancer; 2014 Jul; 22(7):1807-14. PubMed ID: 24531792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy.
    Schaffler-Schaden D; Sassmann R; Johansson T; Gampenrieder SP; Rinnerthaler G; Lampl K; Herfert J; Lenzhofer C; Landkammer YT; Rieder F; Greil R; Flamm M; Niebauer J
    Medicine (Baltimore); 2020 May; 99(19):e20149. PubMed ID: 32384502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-Related Quality of Life in Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Clinical Trial.
    Bao T; Baser R; Chen C; Weitzman M; Zhang YL; Seluzicki C; Li QS; Piulson L; Zhi WI
    Oncologist; 2021 Nov; 26(11):e2070-e2078. PubMed ID: 34390283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
    Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
    Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.
    Ajewole VB; Cox JE; Swan JT; Chikermane SG; Lamoth B; Iso T; Okolo LO; Ford CL; Schneider AM; Hobaugh EC; Baker KR
    Support Care Cancer; 2020 Apr; 28(4):1901-1912. PubMed ID: 31359183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
    Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
    Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study).
    Misawa S; Denda T; Kodama S; Suzuki T; Naito Y; Kogawa T; Takada M; Suichi T; Shiosakai K; Kuwabara S;
    BMC Cancer; 2023 Nov; 23(1):1098. PubMed ID: 37951905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
    Bonhof CS; Trompetter HR; Vreugdenhil G; van de Poll-Franse LV; Mols F
    Support Care Cancer; 2020 Dec; 28(12):5933-5941. PubMed ID: 32281032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Trial of Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy: Crossover Analysis.
    Childs DS; Le-Rademacher JG; McMurray R; Bendel M; O'Neill C; Smith TJ; Loprinzi CL
    J Pain Symptom Manage; 2021 Jun; 61(6):1247-1253. PubMed ID: 33249081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.
    Knoerl R; Mazzola E; Hong F; Salehi E; McCleary N; Ligibel J; Reyes K; Berry DL
    BMC Cancer; 2021 Mar; 21(1):236. PubMed ID: 33676431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy.
    Song SY; Park JH; Lee JS; Kim JR; Sohn EH; Jung MS; Yoo HS
    Integr Cancer Ther; 2020; 19():1534735420925519. PubMed ID: 32493088
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Systematic Review.
    Püsküllüoğlu M; Tomaszewski KA; Grela-Wojewoda A; Pacholczak-Madej R; Ebner F
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy-induced peripheral neuropathy in adolescents: A preliminary study.
    Tomasello C; Pinto RM; Mennini C; Conicella E; Stoppa F; Raucci U
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27064. PubMed ID: 29630779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.